(Q36889236)

English

Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients

scientific article published on June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients (English)

1 reference

Europe PubMed Central

16 August 2017

Cytomegalovirus

0 references

Erik R Dubberke

9

object named as

Erik R Dubberke

1 reference

Europe PubMed Central

16 August 2017

author name string

Bryan T Alexander

1

1 reference

Europe PubMed Central

16 August 2017

Lindsay M Hladnik

2

1 reference

Europe PubMed Central

16 August 2017

Kristan M Augustin

3

1 reference

Europe PubMed Central

16 August 2017

Ed Casabar

4

1 reference

Europe PubMed Central

16 August 2017

Peggy S McKinnon

5

1 reference

Europe PubMed Central

16 August 2017

Richard M Reichley

6

1 reference

Europe PubMed Central

16 August 2017

David J Ritchie

7

1 reference

Europe PubMed Central

16 August 2017

Peter Westervelt

8

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

1 June 2010

1 reference

Europe PubMed Central

16 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

16 August 2017

30

1 reference

Europe PubMed Central

16 August 2017

6

1 reference

Europe PubMed Central

16 August 2017

554-561

1 reference

Europe PubMed Central

16 August 2017

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Prevention and management of cytomegalovirus infection in solid-organ transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

An electronic application for rapidly calculating Charlson comorbidity score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Recent advances in the therapy and prevention of CMV infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Cytomegalovirus prophylaxis and treatment following bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Validation of a combined comorbidity index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Epidemiology and transmission of cytomegalovirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

29 September 2017

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

Treatment of cytomegalovirus pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

Cytomegalovirus pneumonia: the use of ganciclovir in marrow transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

27 June 2018

CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

4 September 2018

Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

4 September 2018

Cytomegalovirus infection after allogeneic stem cell transplant in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

4 September 2018

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

4 September 2018

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668347

4 September 2018

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.6.554

21 January 2018

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid clearance of cytomegalovirus-specific IgG after repeated intravenous infusions of human immunoglobulin into allogeneic bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20500045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1592/PHCO.30.6.554

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36889236&oldid=2088265724"